Physician profile
Peter H Spooner
NPI 1194727438
$5,452.20
in general payments reported to CMS, 2019-2025
33 companies · $1,581 in 2025
The $1,581 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,135 · 2020: $290 · 2021: $523 · 2022: $761 · 2023: $469 · 2024: $693 · 2025: $1,581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,743.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $804.75 | 2025 | Rapiblyk |
| Novartis Pharmaceuticals Corporation | $682.88 | 2019-2025 | |
| Abiomed | $636.09 | 2019-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $428.93 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $342.63 | 2019-2025 | General - Ep, General - Crm_crm |
| Pfizer INC. | $314.13 | 2022-2025 | |
| Cvrx, INC. | $279.61 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $245.27 | 2019-2025 | Eliquis, Camzyos |
| Abbott Laboratories | $187.58 | 2019-2025 | Mitraclip, Triclip |
| Kestra Medical Technology Services, INC. | $178.08 | 2023-2025 | Assure Wcd |
| Medtronic Vascular, INC. | $133.69 | 2019 | |
| Merck Sharp & Dohme LLC | $125.97 | 2021-2023 | Verquvo |
| Edwards Lifesciences Corporation | $114.77 | 2021-2025 | Pascal |
| Impulse Dynamics (USA) INC. | $110.56 | 2023 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.74 | 2019-2025 | Jardiance |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $104.11 | 2019 | |
| Chiesi USA, INC. | $69.48 | 2020-2022 | |
| Welch Allyn | $66.07 | 2021 | |
| Janssen Pharmaceuticals, INC | $62.32 | 2019-2024 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $57.42 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $55.39 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $51.71 | 2019-2022 | |
| Amgen INC. | $50.62 | 2019-2023 | Repatha |
| Bard Peripheral Vascular, INC. | $48.74 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $42.44 | 2019-2024 | Farxiga |
| Novo Nordisk INC | $35.28 | 2022 | |
| Biosense Webster, INC. | $27.50 | 2024 | Carto 3 |
| Esperion Therapeutics, INC. | $17.79 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.42 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $14.61 | 2022 | |
| Alnylam Pharmaceuticals INC. | $14.17 | 2025 | Amvuttra |
| Arbor Pharmaceuticals, INC. | $14.00 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Spooner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.